Details of the Drug

General Information of Drug (ID: DMAF638)

Drug Name

131-I-MIP-1095

Synonyms

MIP-1095 I-131; LFEGKCKGGNXWDV-LUOJOMRDSA-N; UNII-7DM27RQ9V0; 7DM27RQ9V0; Iodine I-131 MIP-1095; Iodine I 131 MIP-1095; 131I-MIP-1095; (131)I-MIP-1095; L-Glutamic acid, N-((((1S)-1-carboxy-5-((((4-(iodo-131I)phenyl)amino)carbonyl)amino)pentyl)amino)carbonyl)-; 1258980-67-4

Indication

Disease Entry	ICD 11	Status	REF
Prostate cancer	2C82.0	Phase 1	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C19H25IN4O8
Canonical SMILES: C1=CC(=CC=C1NC(=O)NCCCCC(C(=O)O)NC(=O)NC(CCC(=O)O)C(=O)O)I
InChI: 1S/C19H25IN4O8/c20-11-4-6-12(7-5-11)22-18(31)21-10-2-1-3-13(16(27)28)23-19(32)24-14(17(29)30)8-9-15(25)26/h4-7,13-14H,1-3,8-10H2,(H,25,26)(H,27,28)(H,29,30)(H2,21,22,31)(H2,23,24,32)/t13-,14-/m0/s1/i20+4
InChIKey: LFEGKCKGGNXWDV-LUOJOMRDSA-N

Cross-matching ID

PubChem CID: 124220556
CAS Number: 1258980-67-4
TTD ID: D06LQF

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)